Related Experiment Video
Updated: Jun 22, 2026
03:32
Measurement of Chitinase Activity in Biological Samples
Published on: August 22, 2019
Macrophage chitinase 1 stratifies chronic obstructive lung disease
Eugene Agapov1, John T Battaile, Rose Tidwell
1Department of Medicine, Washington University School of Medicine, Campus Box 8052, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
Summary
Researchers found that chitinase 1 is elevated in severe chronic obstructive pulmonary disease (COPD) patients, offering a potential noninvasive biomarker. This helps track disease subtypes and improve patient care.
Area of Science:
- Pulmonary Medicine
- Biomarker Discovery
- Immunology
Background:
- Chronic inflammatory lung diseases lack individualized biomarkers for pathogenesis insight.
- Current mouse models of chronic obstructive lung disease (COPD) show increased lung chitinase but don't predict human-specific increases.
Purpose of the Study:
- To identify specific chitinase biomarkers in chronic lung disease.
- To investigate chitinase 1 as a noninvasive marker for alternatively activated macrophages in COPD.
Main Methods:
- Analysis of chitinase production in mouse models of COPD.
- Measurement of chitinase 1 in lung macrophages and plasma from human COPD subjects.
- Correlation of chitinase levels with disease severity and macrophage activation.
Main Results:
- Mouse models showed increased lung chitinase, but not specific family members relevant to human disease.
- Lung macrophage production of chitinase 1 was selectively increased in a subset of severe COPD patients.
- Elevated chitinase 1 in lung macrophages was reflected in plasma levels.
Conclusions:
- Chitinase 1 serves as a noninvasive biomarker for alternatively activated macrophages in chronic lung disease.
- This biomarker can help differentiate molecular phenotypes in heterogeneous COPD patient populations.
- Findings enable better tracking of disease subtypes and personalized therapeutic strategies.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...